Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Malignant Solid Neoplasm 2Teratoma 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Peritoneal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myeloid, Acute 1Hepatitis B 1Hematopoietic and Lymphatic System Neoplasm 1Endodermal Sinus Tumor 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Carcinoma, Embryonal 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1nintedanib 1mercaptoundecahydrododecaborate 1Standard of Care 1Sorafenib 1Practice Guidelines as Topic 1Docetaxel 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Medullary × Practice Guidelines as Topic × Clear all
NCT04467021 2026-05-06

Cancer and Blood Pressure Management, CARISMA Study

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
61 enrolled
Genitourinary

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡